
The Ethics Group of Companies successfully showcased its comprehensive suite of pharmaceutical growth and distribution solutions at iPHEX 2025, held from September 4–6, 2025, at Bharat Mandapam, Pragati Maidan, New Delhi, India.
As one of India’s leading end-to-end supply chain and retail enablement partners, Ethics Group engaged with pharma leaders, healthcare innovators, global sourcing partners, and institutional buyers during the three-day event.
At Stall No. 1B-01, the team demonstrated solutions designed to help pharma and healthcare brands launch, scale, and succeed in India’s dynamic market:
Nationwide Distribution for pharma & OTC brands
End-to-End Pharmacy Retail Chain Solutions
Market Entry Support for international brands entering India
Global Sourcing Partner for WHO-GMP certified pharmaceutical products
Throughout the event, the Ethics Group team held insightful discussions with industry stakeholders on making healthcare more affordable, accessible, and efficient across India and beyond. Visitors explored how Ethics’ technology-driven platform, robust warehousing network, and compliance-driven processes enable measurable growth for both Indian and global brands.
Our participation at iPHEX 2025 reflects our mission to empower pharmaceutical companies with scalable, compliant, and technology-enabled solutions,